Digital-pathology software platform using AI to analyze pathology images
| Date | Round | Amount |
|---|---|---|
| Mar 2024 | Series C Proscia, a digital-pathology AI company, raised a $9M Series C extension (round total $46M) led by Highline Capital Management and Triangle Peak Partners, following FDA clearance. | $46M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.